Publications

Showing

0

out of

0

results

Cost-effectiveness of diagnosing and treating patients with early Alzheimer's disease with anti-amyloid treatment in a clinical setting.

Wimo A, Handels R, Blennow K, ..., Fladby T.

March 20, 2025

Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage.

Goeldlin MB, Fandler-Höfler S, Pezzini A, ... , EURECA collaborators

March 3, 2025

Direct oral anticoagulants versus vitamin K antagonists for cerebral venous thrombosis (DOAC-CVT): an international, prospective, observational cohort study.

van de Munckhof A, van Kammen MS, Tatlisumak T, ... , DOAC-CVT investigators

March 1, 2025

Cognitive improvement after stroke: Prevalence and pattern during the first 3 months.

Etesami MS, Šaltytė Benth J, Kliem E, ... , Grambaite R.

March 1, 2025

Statin Use and Amyotrophic Lateral Sclerosis Survival: A Population-Based Cohort Study.

Vaage AM, Holmøy T, Dahl J, ... , Nakken O

March 1, 2025

Depressive Symptoms and Amyloid Pathology.

Wiels WA, Oomens JE, Engelborghs S, ..., Zettergren A.

March 1, 2025

Blood N-glycomics reveals individuals at risk for cognitive decline and Alzheimer's disease.

Zhou RZ, Gaunitz S, Kirsebom BE, ... , Tjernberg LO

February 20, 2025

Impact of a stroke care pathway on self-perceived health 3 months after stroke.

Bergh E, Askim T, Rønning OM, Lydersen S, Thommessen B.

February 18, 2025

Norwegian normative data for regression-based D-KEFS color-word interference test derived measures and comparison to conventional contrast measures.

Lorentzen IM, Espenes J, Eliassen IV, ... , Kirsebom BE.

February 16, 2025

Subjective cognition in schizophrenia and bipolar disorder: Investigation of group differences and associations with objective cognition and clinical characteristics using a novel measure of subjective cognition.

Grimstad K, Sørensen H, Vaskinn A, ... , Haatveit B

February 3, 2025